Blue Horseshoe Stocks

Fresh Options Plays, Friday’s Multi-Baggers

SolarWinds Corp. SWI – Bottom Watch Play

Many SWI shareholders have been running for the hills following the company’s software being at the center of a major global hacking effort last week, and that’s precisely why we are becoming interested in the stock as a bottom-watch play.

SWI is apparently on track to report a big year-over-year earnings increase, and while the full ramifications of the company’s role in the breaches is not yet known, we want to get out ahead of the crowd and begin monitoring it for a bottom-bounce entry point nonetheless.

Not only will we track the stock, but we’re going to formulate a longer-term options idea to monitor over the next couple of months, with the SWI 02/19 $12.50-17.50 Calls.

Options Reviews

We signaled just two individual contracts for observation on Friday morning, the DRI Weekly $115 Calls and the WGO Weekly $60 Calls, and in both cases, our readers and ourselves had the opportunity to reap multi-bag gains.

DRI Weekly $115 Calls
$77: .75-2.31 (+208%)
_______

WGO Weekly $60 Calls
$255: 1.25-4.55 (+264%)
______

Fresh Options Ideas:
NKE Weekly (12/24) $142-145 Calls
SPY 12/23 $365-367 Calls

Extended Watchlist:
ABML, SFOR, SHMP, APYP, PASO, GRLT, PVDG

Finishing Up a Solid Trading Week

CURE Pharmaceutical Holding Corp. (OTCMKTS:CURR)

As we mentioned in Wednesday morning’s premarket report, CURE officials conducted a Zoom webcast on the current state of the company yesterday afternoon. Today we just wanted to remind our readers that if you were unable to catch the presentation live, you can still get it on demand at the following link: https://zoom.us/webinar/register/WN_BrUIQ-jlR0OkoNC8GNCnhg

CURE has a lot happening right now, so we would highly suggest getting the story straight from the horse’s mouth and hearing what company directors had to say.
_______

Direct all investor inquiries on CURR to:

Gary Zwetchkenbaum
Plum Tree Consulting LLC
Phone: (718) 224-3123
Cell: (516) 455-7662
Website: www.plumtreeconsultingllc.com

Options Recaps

Our LEN and ACN idfeas from yesterday’s report panned out pretty well, and we have a couple of fresh ideas to add to the mix as well.

LEN Weekly $75.50-77 Calls
$75.50: 2.55-6.14 (+140%)
$76: 2.26-5.60 (+148%)
$76.50: 1.51-5.10 (+238%)
$77: 1.35-4.90 (+263%)
_______

ACN Weekly $255-262.50 Calls
$255: 9.99-15.00 (+50%)
$257.50: 8.19-12.30 (+50%)
$260: 5.79-10.01 (+73%)
$262.50: 4.15-9.00 (+117%)
______

Fresh Options Ideas:
WGO Weekly $60 Calls
DRI Weekly $115 Calls

Extended Watchlist:
BSRC, CEOS, SAML, TEUM, BCII, CBGH

PBIO News, Options Ideas

Pressure BioSciences, Inc. (OTCMKTS:PBIO)

We are checking in with PBIO this morning, as the company released a PR pertaining to the adoption of its Pressure Cycling Technology (PCT) in coronavirus research, which you’ll find below. We are also still awaiting news of the company’s partnership with Cannaworx, and the launch of its FDA-registered immune booster this month, as indicated by PBIO on December 4th.

Since we began tracking this stock, we have witnessed an impressive trading range as PBIO has moved from a low of 1.80 to yesterday’s new high of 2.75. That works out to an upswing of 53% inside of two weeks, and gives us plenty of reason to be interested in what comes next.

SOUTH EASTON, Mass., Dec. 17, 2020 /PRNewswire/ — Pressure BioSciences, Inc. (OTCQB: PBIO) (“PBI” or the “Company”), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide biotechnology, biotherapeutics, cosmetics, nutraceuticals, and food & beverage industries, today announced a remarkable convergence of global research teams announcing pivotal new insights into COVID-19 biology and disease processes. These data point to potential new pathways to next generation diagnostics and treatments. All teams selected PBI’s Pressure Cycling Technology (“PCT”) platform for their critical sample preparation steps, to help ensure that the greatest abundance and diversity of reproducible results would be revealed in the thousands of proteins involved in the affected biochemical pathways. (>>View Full PR via OTCMARKETS)
_____

We also have a video presentation on the PBIO chart that we would suggest our readers take a moment to view:

PBIO Video Chart
_____

For All Investor Inquiries on PBIO,Contact:
Gary Zwetchkenbaum, Plum Tree Consulting LLC
Email: gzplumtree@gmail.com
Phone: (516) 455-7662
Web: plumtreeconsultingllc.com

The Toro Co. TTC – Recap

We included the TTC Weekly $90-95 Calls as a possible options trading idea in yesterday morning’s premarket report. With the help of a solid day for the markets as a whole, and the company reporting strong figures for both Q4 and the the 2020 Fiscal Year, we saw instant results.

Here are the total possible intraday gains that were on the table for those targets:

TTC Weekly $90-95 Calls
$90: 1.15-2.61 (+127%)
$95: .05-.15 (+200%)

_____

Fresh Options Ideas:
JBL Weekly $43.50-45 Calls
LEN Weekly $75.50-77 Calls
ACN Weekly $255-262.50 Calls

Fresh Options Ideas, CURR Investor Webcast Info

CURE Pharmaceutical Holding Corp. (OTCMKTS:CURR)

As we were just pointing out in yesterday morning’s premarket report, CURE was slated to present at LD Micro Main Event Conference yesterday afternoon, and that event went off without a hitch. You can view the company’s full 20-minute presentation by registering at the LD Micro website HERE, navigating to Tuesday’s tab, and looking in the 2PM slot for CURE Pharmaceuticals.

It’s also important to note that CURE will be hosting a Zoom webcast tomorrow at 4PM EST, regarding, among other things, the company’s current strategic positioning.

You can register to participate in the conference, and/or listen to an archived copy at a later time, at the following link: https://zoom.us/webinar/register/WN_BrUIQ-jlR0OkoNC8GNCnhg

Direct all investor inquiries on CURR to:

Gary Zwetchkenbaum
Plum Tree Consulting LLC
Phone: (718) 224-3123
Cell: (516) 455-7662
Website: www.plumtreeconsultingllc.com

Fresh Options Ideas
BOIL Weekly $23-25 Calls
TTC Weekly $90-95 Calls
FDX Weekly $285-290 Calls

Extended Watchlist:
BITW, BLDV, TMXN, DIGAF, MMEDF, CELZ

CURR News Update & More

CURE Pharmaceutical Holding Corp. (OTCMKTS:CURR)

The last time we looked in on CURE Pharma, the company had just announced a new brand ambassadorship for the company’s wholly-owned SeraLabs subsidiary with award-winning actress Nicole Kidman. Today, we’re tracking back once again to share a fresh PR.

The news released by CURR yesterday pertains to two key events that are taking place today and Thursday, that will be of interest to both current and potential shareholders alike:

CURE Pharmaceutical Holdings (“CURE” or the “Company”) (OTCQB: CURR), a holding company focused on the innovation of pharmaceutical technology, wellness products and drug delivery, today announced that management will present on the company at the LD Micro Main Event Conference on Tuesday, December 15, 2020 at 11:00 AM Pacific Time. Additionally, the Company will host a video webcast with the investment community on Thursday, December 17, 2020, at 4:00 p.m. Eastern Standard Time

On the Investor Video Webcast, Rob Davidson, CEO of CURE, Nancy Duitch, CEO of wholly-owned subsidiary The Sera Labs and Chief Strategy Officer for the Company, and Mike Redard, CFO of CURE, will present on the Company’s strategic positioning among other topics and will address shareholder questions at the end of the webcast.

To register for this webcast, please use the link below:
https://zoom.us/webinar/register/WN_BrUIQ-jlR0OkoNC8GNCnhg

(>>View Full PR)

More OTC Runners

We have recently tagged a number of other OTC traded stocks in our extended watchlist, which have produced significant gain opportunities. It’s very important that our readers don’t simply gloss over these added stocks to track, which are included in most of our premarket reports.

In the case of HAVLF, ZAAG, and AEPT, we just flagged them for observation yesterday morning and they instantly delivered premium chances for a quick profit. ALPP first began appearing in our daily report on November 20th, and has since made an excellent move.

Havn Life Sciences Inc. HAVLF
Range: .62-1.25 (+102%)
_____

ZA Group, Inc. ZAAG
Range: .0225-.038 (+69%)
_____

American Energy Partners, Inc. AEPT
Range: .0081-.0179 (+121%)
_____

Alpine 4 Technologies, Ltd. ALPP
Range: .152-1.20 (+689%)

Weibo Corp. WB – Update

We tagged the WB Weekly $40-41 Calls and we did see a solid move from the $40’s from 1.55-2.75 (+77%). We’ll continue to track these targets as the week progresses, which should produce further positive activity if the current hopes for another coronavirus stimulus package hold true.

Extended Watchlist:
RVVTF, LKYSF, DFCO, SHMP, AITX, CYTR, HSTRF, PEMTF